Re: Using the 21-Gene Assay From Core Needle Biopsies to Choose Neoadjuvant Therapy for Breast Cancer: A Multicenter Trial. Journal of Surgical Oncology 2017;115(8):917-923.
Journal of Surgical Oncology - United States
doi 10.1002/jso.24798
Full Text
Open PDFAbstract
Available in full text
Date
July 28, 2017
Authors
Publisher
Wiley